Gilead Sciences (GILD) Tops Q3 EPS by 14c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $124.87 +0.90%
EPS Growth %: -462.7%
Financial Fact:
Cost of goods sold: 1.13B
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -462.7%
Financial Fact:
Cost of goods sold: 1.13B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $2.27, $0.14 better than the analyst estimate of $2.13. Revenue for the quarter came in at $6.51 billion versus the consensus estimate of $6.39 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
